Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Clavulanic acid Clindamycin

To prevent development of resistance and promote synergy, inhaled tobramycin or colistin is usually added to an oral fluoroquinolone for P. aeruginosa coverage.1,3 Methicillin-sensitive S. aureus (MSSA) may be treated with oral amoxiciUin-clavulanic acid, dicloxacillin, first- or second-generation cephalosporins, trimethoprim-sulfamethoxazole, or clindamycin, depending on sensitivity. Likewise, methiciUin-resistant S. aureus (MRSA) may be treated with oral trimethoprim-sulfamethoxazole, clindamycin, minocycline, or linezolid. H. influenzae often produces... [Pg.250]

In a recent study, the bacterial populations contaminating the upper gut in SIBO patients and their antibiotic susceptibility were determined. Amoxicillin-clavulanic acid and cefoxitin were effective against >90% of anaerobic strains, while aminopenicillins, cephalosporins and cotrimoxazole were effective against the microaerophilic population. Erythromycin, clindamycin and rifampicin were ineffective. Data on metronidazole and fluoroquinolones are not available [32]. [Pg.106]

Patients with noninfected bite injuries should be given prophylactic antibiotic therapy for 3 to 5 days. Amoxicillin-clavulanic acid (500 mg every 8 hours) is commonly recommended. Alternatives for penicillin-allergic patients include fluoroquinolones or trimethoprim-sulfamethoxazole in combination with clindamycin or metronidazole. First-generation cephalosporins, macrolides, clindamycin alone, or aminoglycosides are not recommended, as the sensitivity to E. corrodens is variable. [Pg.534]

Obstetric infections can be treated with penicillin-beta-lactamase inhibitors such as amoxicillin-clavulanic acid, with extended spectrum penicillins (with or without beta-lacamase inhibitors if justified by local resistance surveillance data), with a first or second generation cephalosporin combined with metronidazole. In severe cases of streptococcal infection high doses of penicillin in combination with clindamycin is the treatment of choice. In amnionitis, maternal morbidity resolves with delivery. In endometritis, antibiotics should be stopped after the... [Pg.537]

Broad spectrum therapy is started on an empirical basis. Intra-abdominal infections can be treated by ampicillin (or amoxycillin) or clindamycin combined with aminoglycosides, penicillin-beta-lacta-mase inhibitors such as amoxycillin-clavulanic acid or a second or third generation cephalosporin combined with metronidazole are good alternatives. In patients with impaired immunity and/or prior use of antibiotics, i.e. when it is reasonable to expect resistant pathogens, a broad spectrum penicillin plus beta-lactamase inhibitor or a carbapenem can be used empirically in monotherapy. In septic patients, the rapidly bactericidal action of aminoglycosides is useful. Aminoglycosides should preferentially not be given for more than 3-5 days. [Pg.540]

For infected bite wounds, penicillin and a peniciUinase-resistant penicillin or amoxiciUin-clavulanic acid 875 mg/125 mg oraUy twice daily (40 mg/kg per day oraUy of the amoxicillin component divided into two doses) should be started empirically pending the culture results. Tetracyclines or a combination of clindamycin plus a fluoroquinolone or trimethoprim-sulfamethoxazole may be used as an alternative therapy for the penicillin-allergic patient. Hospitalization for minor wounds is not necessary if surgical repair of vital structures has not been performed. Patients suffering serious injuries or clenched-fist injuries should be started on intravenous antibiotics. Duration of therapy for infected bite injuries should be 7 to 14 days. [Pg.1993]

Of the drugs listed, only chloramphenicol, clindamycin, and ticarciUin (with clavulanic acid) are reliably active against B fragilis. Chloramphenicol is a broad-spectrum antibiotic, and ticarciUin inhibits bacterial cell waU synthesis. The answer is (C). [Pg.394]

MRSA Methicillin-Resistant Staphylococcus aureus, ARP Antibiotic Resistance Profile AMC Amoxicillin-Clavulanic acid C-Chloramphenicol F Furazolidone Fc FlOTfenicol Gm Gentamycin N Neomycin NAL Nalidixic acid S Streptomycin Su Sulfonamides TFT Tetracycline TMP Trimetoprim AMP ampieillin PEN penicillin OXA oxacillin MET methicillin AXO ceftriaxone CIP ciprofloxacin LEVO levofloxacin GAT gatifloxacin ERY et34bromycin CLI clindamycin CL Cephalexin... [Pg.21]


See other pages where Clavulanic acid Clindamycin is mentioned: [Pg.504]    [Pg.504]    [Pg.504]    [Pg.504]    [Pg.197]    [Pg.1987]    [Pg.77]    [Pg.126]   
See also in sourсe #XX -- [ Pg.5 , Pg.20 , Pg.71 , Pg.250 ]




SEARCH



Clavulanic acid

Clavulanic acid/clavulanate

Clindamycin

© 2024 chempedia.info